UNC Eshelman School of Pharmacy, United States Pharmacopeial Convention launch fellowship opportunity

June 26, 2019

The UNC Eshelman School of Pharmacy in partnership with the United States Pharmacopeial Convention (USP), is launching a new fellowship opportunity that will help address economic gaps in medicines quality research. USP, a global health organization that works with experts in science and health to develop independent, transparent standards for quality in medicines and other health products, will be sponsoring a fellow hosted at UNC through the Fellowship in Quality of Medical Products. The program will offer the opportunity for a fellow to work with leading experts in the field of economics of medicines quality research, filling in critical evidence … Continued

Fake, Low-Quality Medicines Burden Developing World, UNC Study Finds

August 10, 2018

More than 13 percent of essential medicines in low- and middle-income countries are substandard or fake, according to recent findings from the University of North Carolina at Chapel Hill. Sachiko Ozawa, Ph.D., M.H.S., an associate professor at the UNC Eshelman School of Pharmacy, led a meta-analysis of 96 studies that examined the problem of substandard or falsified medicines in low- and middle-income countries. The researchers found that 13.6 percent of medicines were substandard or falsified, including 18.7 percent of medicines in African countries. “The prevalence of substandard and falsified medicines is a substantial public health problem,” she said. “Our study … Continued

Vaccines Save 20 Million Lives, $350 billion in Poor Countries since 2001

September 1, 2017

Vaccination efforts made in the world’s poorest countries since 2001 will have prevented 20 million deaths and saved $350 billion in health-care costs by 2020, according to a new analysis from the University of North Carolina at Chapel Hill. In addition, the researchers put the broader economic and social value of saving these lives and preventing disabilities at $820 billion. Researchers led by Sachiko Ozawa, Ph.D., an associate professor at the UNC Eshelman School of Pharmacy, studied the economic impact of Gavi, the global vaccine alliance launched in 2000 to provide vaccines to children in the world’s poorest countries. Gavi … Continued

Sachiko Ozawa Joins PACE as Associate Professor

October 17, 2016

Sachiko Ozawa, Ph.D., M.H.S., has joined the UNC Eshelman School of Pharmacy as an associate professor in the Division of Practice Advancement and Clinical Education. Ozawa’s principal research interests are in global health economics and outcomes, including estimating the value of vaccines, assessing the global economic burden of diseases and examining the demand and utilization of health care in low- and middle-income countries. She will be leading an internationally recognized and highly collaborative funded research program in global health economics and outcomes, as well as teaching and mentoring students and lending her expertise to the planning and implementation of the … Continued

Unvaccinated Adults Cost the U.S. More than $7 Billion a Year

October 12, 2016

Vaccine-preventable diseases among adults cost the U.S. economy $8.95 billion in 2015, and unvaccinated individuals are responsible for 80 percent, or $7.1 billion, of the tab, according to the most comprehensive analysis to date from the UNC Eshelman School of Pharmacy. Researchers led by Associate Professor Sachiko Ozawa studied 10 vaccines recommended by the Centers for Disease Control and Prevention. The study, published in the journal Health Affairs, examined the actual cost of inpatient and outpatient care, cost of medication and the value of productivity lost from time spent seeking care. The ten vaccines protect against 14 pathogens: hepatitis A, hepatitis … Continued